These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22828795)

  • 1. Long-term changes in neointimal hyperplasia following implantation of bare metal stents assessed by integrated backscatter intravascular ultrasound.
    Tanaka S; Noda T; Iwama M; Tanihata S; Kawasaki M; Nishigaki K; Minagawa T; Watanabe S; Minatoguchi S
    Heart Vessels; 2013 Jul; 28(4):415-23. PubMed ID: 22828795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents.
    Muraoka Y; Sonoda S; Kashiyama K; Kamezaki F; Tsuda Y; Araki M; Okazaki M; Otsuji Y
    Int J Cardiovasc Imaging; 2012 Oct; 28(7):1635-41. PubMed ID: 22179946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of neointimal tissue characterization and heterogeneity of bare-metal stents and drug-eluting stents on the time course after stent implantation evaluated by integrated backscatter intravascular ultrasound.
    Yoshizane T; Tanaka S; Abe S; Ueno T; Goto Y; Kojima T; Iwama M; Arai M; Noda T; Kawasaki M
    Heart Vessels; 2019 Oct; 34(10):1639-1649. PubMed ID: 30997558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neointimal tissue component assessed by tissue characterization with 40 MHz intravascular ultrasound imaging: comparison of drug-eluting stents and bare-metal stents.
    Tsujita K; Takaoka N; Kaikita K; Hokimoto S; Horio E; Sato K; Mizobe M; Nakayama N; Kojima S; Tayama S; Sugiyama S; Nakamura S; Ogawa H
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1068-74. PubMed ID: 23460385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
    Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS).
    Jensen LO; Vikman S; Antonsen L; Kosonen P; Niemelä M; Christiansen EH; Kervinen K; Erglis A; Harnek J; Kumsars I; Thuesen L; Niemelä K
    Cardiovasc Revasc Med; 2017 Dec; 18(8):577-582. PubMed ID: 29066343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of integrated backscatter intravascular ultrasound in characterizing bare metal and drug-eluting stent restenotic neointima as compared to optical coherence tomography.
    Sato K; Costopoulos C; Takebayashi H; Naganuma T; Miyazaki T; Goto K; Yamane H; Hagikura A; Kikuta Y; Taniguchi M; Hiramatsu S; Ito H; Colombo A; Haruta S
    J Cardiol; 2014 Dec; 64(6):488-95. PubMed ID: 24794757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
    Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal dysfunction and atherosclerosis of the neointima following bare metal stent implantation.
    Hayano S; Ishii H; Ichimiya S; Kanashiro M; Watanabe J; Suzuki S; Yoshikawa D; Maeda K; Matsubara T; Murohara T
    Am J Nephrol; 2013; 38(1):58-65. PubMed ID: 23838572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
    Araki T; Nakamura M; Sugi K
    J Cardiol; 2014 Dec; 64(6):423-9. PubMed ID: 24794755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions.
    Choi W; Chae IH; Park JJ; Kim SH; Kang SH; Oh IY; Yoon CH; Cho YS; Youn TJ; Choi DJ
    Korean J Intern Med; 2019 Jul; 34(4):819-829. PubMed ID: 29961306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
    Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue characteristics of neointima in late restenosis: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
    Ando H; Suzuki A; Sakurai S; Kumagai S; Kurita A; Waseda K; Takashima H; Amano T
    Heart Vessels; 2017 May; 32(5):531-538. PubMed ID: 27730297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial.
    Burzotta F; Brancati MF; Trani C; Pirozzolo G; De Maria G; Leone AM; Niccoli G; Porto I; Prati F; Crea F
    Heart Vessels; 2016 May; 31(5):677-86. PubMed ID: 25863804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.